Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Yes, symptom distress — including post-dialysis fatigue, itching, anxiety, and depression — significantly reduces quality of life in hemodialysis patients.
Yes, changes in immune cells and their energy metabolism can predict outcomes like rejection and infection risk in liver transplant recipients.
Yes, a post-hoc analysis of the AFIRE trial found that in patients with atrial fibrillation and stable CAD, lower baseline systolic blood pressure (≤126 mmHg) was linked to…
Yes, recent trials show endovascular thrombectomy improves functional outcomes in patients with large vessel occlusion and low ASPECTS (≤5), though risks remain.
Doctors use clinical scores, imaging, and biomarkers to predict futile LVO stroke treatment, but no single tool is perfect.
Recent reviews show MASLD is the leading cause of chronic liver disease, drives liver transplant needs, and involves complex links between gut bacteria, circadian rhythms, and…
Direct transfer to an angiography suite for severe large vessel occlusion stroke does not improve long-term recovery and may increase the risk of bleeding complications.
Recent reviews highlight lifestyle changes and emerging drugs like resmetirom, but no universally validated treatment exists yet for MASLD.
A 2024 trial found that taking CN-105 before noncardiac surgery reduced serious adverse events in older adults compared to a placebo.
Capnography shows high diagnostic accuracy for detecting diabetic ketoacidosis by showing significantly lower carbon dioxide levels in affected patients compared to those without…
Synthetic inhibitors treat ischemia-reperfusion injury by blocking specific cell death pathways like ferroptosis and PANoptosis, suppressing harmful inflammation via the NLRP3…
Yes, animal studies show metformin can protect the heart from ischemia-reperfusion injury by reducing cell death, oxidative stress, and inflammation.
Yes, changes in immune cells like Kupffer cells and the broader microbiota directly worsen liver transplant outcomes by driving inflammation and tissue damage during…
Yes, preclinical studies show trimetazidine reduces ischemia-reperfusion injury in organs like the heart and liver, but human trials are limited.
Research indicates that high levels of the TWEAK-Fn14 axis are linked to brain injury and heart problems, making it a target for treating brain-heart syndrome.
Natural compounds like oridonin show promise against ischemia-reperfusion injury by suppressing inflammation and targeting specific cell death pathways, though more clinical…
Ultrasound markers of adenomyosis, especially direct ones like cysts, are linked to lower live birth rates and higher pregnancy loss during IVF.
Yes, MRgFUS can reduce adenomyosis symptoms like heavy bleeding and pain, with studies showing significant improvement in quality of life and reduced lesion size.
Yes, adenomyosis is linked to higher pregnancy loss rates in IVF, with studies showing a 2- to 3-fold increased risk, especially in diffuse or severe disease.
Yes, fluoridated water helps prevent cavities by strengthening enamel and reducing acid damage, though many U.S. systems face challenges in maintaining optimal levels.
Adenomyosis location matters: intrinsic (inner) disease may worsen IVF outcomes more than extrinsic (outer) disease, and diffuse involvement of the junctional zone is linked to…
Adenomyosis reduces live birth rates in IVF, especially with direct ultrasound markers or diffuse disease, and increases pregnancy loss risk.
Stroke and spinal cord injury share similar underlying causes for spasticity, primarily involving maladaptive changes in the central nervous system and plastic changes in the…
A 2024 trial found that active transcutaneous spinal cord stimulation reduced restless legs symptoms significantly more than a fake (sham) treatment over two weeks.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.